-
-
1 × $730.00 -
1 × $365.00 -
1 × $179.00 -
1 × $2.40 -
2 × $2.50 -
1 × $1,251.22 -
2 × $923.00 -
1 × $2.75 -
1 × $209.00 -
2 × $375.00 -
1 × $436.00 -
1 × $99.00 -
-
-
-
1 × $600.00 -
1 × $579.00 -
-
1 × $666.00 -
-
1 × $3.00 -
-
1 × $369.00 -
1 × $99.90 -
-
1 × $232.00 -
-
1 × $158.00 -
1 × $149.00 -
1 × $2.55 -
1 × $3.80 -
1 × $199.00 -
1 × $9.00 -
1 × $167.00 -
1 × $4.20 -
1 × $193.00 -
1 × $232.00 -
1 × $164.00 -
1 × $2.50 -
-
1 × $2.50 -
1 × $2.50 -
1 × $5,016.00 -
1 × $2.20 -
2 × $3.50
Hepcinat-LP, also known as “HARVONI®, Hepcvilr L, Myhep lvir” is a fixed-dose combination of Sofosbuvir and Ledipasvir indicated for the treatment of chronic hepatitis C virus (HCV). Hepcinat-LP combines Sofosbuvir 400mg and Ledipasvir90mg. Its Cure rates is 94% to 99% for hepatitis C. Sofosbuvir 100mg/Velpatasvir 40 mg’s brand name is HARVONI® by Gilead. Hepcinat-LP is a generic oncologic prescription medicine from Natco, which is one of the biggest pharmaceutical company in India.
Reviews
There are no reviews yet.